company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14311000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,460000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2548000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2548000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12223000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4089000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3856000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,298000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8243000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3980000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,496000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,309000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-187000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3793000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,715000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1117000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.76
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1123000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.74
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1115200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2007.0,FY,2007-01-01,2007-12-31,2010-03-01 13:04:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.76
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14687000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,316000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15003000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12707000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4169000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3030000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7493000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5214000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,551000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,352000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5015000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,963000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4052000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4052000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4052000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1070000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1075000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1069100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,FY,2008-01-01,2008-12-31,2011-02-25 16:38:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3784000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,91000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3875000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,677000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,677000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3198000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,912000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,729000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1715000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1483000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,133000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,62000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-71000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1412000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,291000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1121000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1121000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1121000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1058000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1064000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1057500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q3,2008-07-01,2008-09-30,2009-11-06 17:10:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,72000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,515000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,515000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3249000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1188000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,809000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2070000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1179000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,137000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1130000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,224000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,906000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,906000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,906000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1078600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2008.0,Q2,2008-04-01,2008-06-30,2009-08-07 19:09:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3743000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,66000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3809000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,538000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,538000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3271000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1184000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,891000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2148000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1123000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,142000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,94000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1075000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,931000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,931000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,931000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.93
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.92
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1016600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.92
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14351000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,291000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14642000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2091000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2091000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12551000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3887000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2864000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7045000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5506000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,578000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-302000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5204000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,599000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.53
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.51
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1016600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,FY,2009-01-01,2009-12-31,2012-02-29 06:02:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.53
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10608000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,225000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10833000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9280000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2703000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1973000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4897000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4383000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,436000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,182000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-254000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4129000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,455000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.6
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1019100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3736000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,76000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3812000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,545000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,545000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3267000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,941000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,647000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1662000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1540000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,154000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1386000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1386000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1386000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1016000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1019100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q3,2009-07-01,2009-09-30,2010-11-08 15:23:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6872000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,149000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1008000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1008000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6013000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1326000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3235000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2778000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,297000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,108000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-189000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2589000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,301000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2288000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2288000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2288000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1013000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.24
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.23
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1015200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3634000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,79000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3713000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,531000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,531000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3182000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,693000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1725000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1457000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-100000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1357000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,88000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1269000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1269000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1269000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1013000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1015200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q2,2009-04-01,2009-06-30,2010-08-09 13:57:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3238000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,70000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3308000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,477000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,477000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2831000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,803000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,633000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1510000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1321000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,58000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-89000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1232000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,213000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1019000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1019000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1019000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1032000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.99
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1037000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2009.0,Q1,2009-01-01,2009-03-31,2010-05-07 16:31:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.98
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,81000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3841000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,572000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,572000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3269000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1274000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,854000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2201000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,93000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-69000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,999000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-23000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,960000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,965000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.08
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,960000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14660000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,393000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15053000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2220000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2220000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12833000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4100000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7288000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5545000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,604000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,376000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-228000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5317000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,690000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4627000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4627000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4627000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,960000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.82
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,965000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,960000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,FY,2010-01-01,2010-12-31,2013-02-27 16:18:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.82
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10900000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,312000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1648000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1648000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9564000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2826000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2040000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5087000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4477000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,442000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,283000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-159000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4318000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,713000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,962000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,958100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14643000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,378000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2186000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2186000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12835000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4010000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2931000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7235000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5600000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,584000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,377000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-207000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5393000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,857000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4536000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4536000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4536000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.66
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,962000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,958100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,57000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3816000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3229000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,957000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,719000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1479000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,105000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1434000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,198000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1236000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1236000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1236000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.29
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,962000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,958100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.29
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q3,2010-07-01,2010-09-30,2011-11-04 06:10:39+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7141000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,255000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7396000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1061000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1061000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6335000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1869000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1321000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3337000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2998000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,292000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,178000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-114000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2884000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,515000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2369000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2369000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2369000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,964000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.43
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,961600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14620000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,397000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12873000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3994000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2859000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5726000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,573000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,346000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-227000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5499000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,813000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4686000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4686000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4686000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,964000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,961600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3613000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,191000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3804000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3251000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,986000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,675000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1734000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1517000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,94000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-53000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1464000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,262000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,964000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,961600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q2,2010-04-01,2010-06-30,2011-08-08 14:54:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14641000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,285000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14926000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2122000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2122000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12804000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3967000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2877000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7138000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5666000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,576000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,302000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-274000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5392000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,639000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,982000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,988000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,980700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3528000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,64000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3592000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,508000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,508000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3084000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,883000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,646000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1603000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1481000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,145000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,84000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-61000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1420000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,253000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,982000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.19
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,988000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.18
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,980700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2010.0,Q1,2010-01-01,2010-03-31,2011-05-10 13:12:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.19
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3907000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,66000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3973000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,937000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,937000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3036000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,851000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1874000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,195000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,84000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-111000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1051000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,117000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,934000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,934000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,934000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,905000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,912000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,904900000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15295000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,287000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15582000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2708000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2708000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12874000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5395000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4312000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,610000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,448000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,467000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3683000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3683000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3683000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,905000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.07
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,912000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.04
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,904900000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,FY,2011-01-01,2011-12-31,2014-02-24 16:07:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.07
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11388000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11609000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9838000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2316000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6688000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,415000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,364000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3099000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,350000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2749000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2749000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2749000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,907000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.97
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,914000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.95
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,908000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.97
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15148000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,302000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15450000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2343000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2343000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5425000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3170000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8889000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4218000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,577000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,457000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-120000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4098000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,327000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,907000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,914000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.03
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,908000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3877000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,67000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1979000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,525000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,158000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,87000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-71000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,454000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,454000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,454000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,454000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,907000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,914000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,908000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q3,2011-07-01,2011-09-30,2012-11-06 16:47:49+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7511000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,154000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7665000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1166000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1166000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6499000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2172000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1555000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3874000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2625000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,20000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,350000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2295000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2295000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2295000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,927000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,928600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15030000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,292000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15322000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2325000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2325000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12997000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4403000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3128000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7825000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5172000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,569000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,475000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-94000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,525000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,927000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,928600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3893000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,66000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3357000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1133000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,819000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,73000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2025000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1332000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,122000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,129000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,7000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,169000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1170000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1170000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1170000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,927000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.26
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,928600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.26
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q2,2011-04-01,2011-06-30,2012-08-08 17:03:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,417000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12891000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4256000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2984000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7534000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5357000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,594000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,440000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-154000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5203000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4585000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4585000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4585000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,933000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,941000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,929800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,88000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3706000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,564000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,564000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3142000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1039000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,736000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1849000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1293000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,135000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,148000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1306000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,181000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1125000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1125000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1125000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,933000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,941000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,929800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2011.0,Q1,2011-01-01,2011-03-31,2012-05-08 06:03:22+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4337000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,84000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4421000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,922000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,922000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3499000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1473000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,938000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2411000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1088000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,291000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,923000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,775000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.04
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,787000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.02
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,774500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.04
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.08
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16639000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,626000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14066000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5109000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3380000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8489000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5577000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1053000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,485000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-568000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,664000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4345000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4345000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4345000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,775000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,787000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,774500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,FY,2012-01-01,2012-12-31,2015-02-19 17:06:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12302000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,542000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12844000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10567000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3636000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2442000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4489000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,359000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-403000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4086000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.57
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,783000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,768800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.57
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.08
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16209000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,608000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16817000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3214000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3214000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13603000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4880000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3293000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-221000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7952000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5651000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,957000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,443000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-514000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5137000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,646000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4491000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4491000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4491000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.67
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,783000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,768800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.67
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4201000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,118000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4319000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,775000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,775000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3544000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1241000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,880000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2121000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1423000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,271000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,111000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-160000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1263000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,156000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.44
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,783000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,768800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.44
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q3,2012-07-01,2012-09-30,2013-10-29 17:22:48+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8101000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,424000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8525000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1502000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1502000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7023000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2395000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3957000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3066000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,491000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,248000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-243000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2823000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,373000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2450000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2450000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2450000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,776000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,785000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,776700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15885000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16442000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3044000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3044000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13398000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,844000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,419000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-425000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4328000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,490000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3838000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3838000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3838000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,776000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,785000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.68
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,776700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4200000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4477000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3725000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1310000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,826000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2136000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1589000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,256000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,124000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-132000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1457000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1266000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1266000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1266000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,776000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,785000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,776700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q2,2012-04-01,2012-06-30,2013-08-06 17:10:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15578000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,346000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15924000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13030000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5441000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3167000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,-74000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8534000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4496000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,710000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,424000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-286000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4210000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,468000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3742000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3742000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3742000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,791000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,789300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3901000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4048000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3298000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1085000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,736000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1821000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1477000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,235000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,124000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-111000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1366000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,182000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1184000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1184000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1184000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,791000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,800000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,789300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 16:23:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18192000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,484000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18676000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3346000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3346000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15330000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5380000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4083000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9463000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5867000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,420000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,184000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.75
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,765000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.64
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,752700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,FY,2013-01-01,2013-12-31,2016-02-16 07:00:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.75
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4799000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5011000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1029000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1029000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3982000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1546000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1249000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2795000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1187000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1014000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-7000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,765000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,752700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13393000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,272000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13665000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2317000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2317000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11348000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3834000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2834000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6668000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4680000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,332000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-429000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4251000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,191000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4060000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4060000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4060000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.39
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,766000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,755800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.39
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17730000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,356000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18086000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3239000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3239000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14847000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5307000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3772000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9079000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1052000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,458000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-594000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,326000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4848000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4848000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4848000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.43
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,766000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.34
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,755800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.43
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4647000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,101000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4748000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3960000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1283000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,989000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2272000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1688000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-185000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1503000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1368000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1368000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1368000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,766000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,755800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q3,2013-07-01,2013-09-30,2014-10-29 16:46:52+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8746000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8917000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7388000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2551000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1845000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4396000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2992000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,504000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,260000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2748000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,56000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.58
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.53
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,753300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.58
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.94
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17284000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,373000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17657000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3226000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3226000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14431000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3663000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5503000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1066000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,497000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-569000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4934000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,347000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.96
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,753300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.22
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4595000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,84000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4679000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,785000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,785000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1377000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,967000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2344000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1550000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,241000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,96000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-145000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1405000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1258000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1258000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1258000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.67
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,753300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.67
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q2,2013-04-01,2013-06-30,2014-08-05 16:06:09+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16889000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,566000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17455000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3193000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3193000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14262000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5198000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3522000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8720000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5542000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,525000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-556000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4986000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,391000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4595000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4595000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4595000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.02
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.92
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,750800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.02
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.11
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,87000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4238000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,744000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,744000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3494000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,878000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2052000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1442000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,263000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-99000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1343000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-91000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1434000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1434000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1434000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.91
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,750800000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.91
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2013.0,Q1,2013-01-01,2013-03-31,2014-04-30 16:18:43+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19327000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,736000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20063000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4422000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4422000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15641000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5153000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4297000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9450000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6191000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,465000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-606000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5585000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,427000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5158000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5158000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5158000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.8
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,FY,2014-01-01,2014-12-31,2017-02-14 16:21:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.8
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,157000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5331000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1183000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1183000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4148000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1455000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1234000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2689000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1459000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,261000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,88000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-173000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1286000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.68
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.83
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4848000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,183000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5031000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3963000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1479000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1018000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2497000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1466000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,269000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,140000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-129000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1337000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,93000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,763200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3,2014-07-01,2014-09-30,2015-11-02 06:09:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14153000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,579000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14732000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3239000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3239000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11493000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3698000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3063000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4732000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,810000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,377000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4299000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,435000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3864000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3864000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3864000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.02
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,763200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.83
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18952000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,791000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19743000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4268000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4268000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15475000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5244000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4312000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9556000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5919000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,465000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-606000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5313000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,428000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4885000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4885000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4885000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,771000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.34
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,763200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9305000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,396000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9701000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7530000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2219000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2045000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4264000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3266000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,541000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,237000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-304000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2962000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,342000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2620000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2620000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2620000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.46
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.46
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.22
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,709000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19460000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3988000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3988000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15472000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5048000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4283000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9331000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6141000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,397000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-662000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5479000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,470000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.28
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4949000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,231000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5180000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1081000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4099000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1179000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1018000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2197000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1902000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,282000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,138000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1758000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,211000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1547000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1547000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1547000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,759000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.04
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.01
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.04
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q2,2014-04-01,2014-06-30,2015-08-05 06:04:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18397000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18959000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15267000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5246000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4232000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9478000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5789000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1018000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,355000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-663000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,406000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4720000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4720000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4720000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,757000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.26
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.16
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,755600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.26
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.14
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4356000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4521000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1090000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1090000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3431000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1040000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1027000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1364000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,259000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,99000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-160000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1204000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,131000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1073000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1073000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1073000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,757000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.42
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,755600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.42
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2014.0,Q1,2014-01-01,2014-03-31,2015-04-27 06:14:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,718000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21662000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4227000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4227000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17435000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4895000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4070000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8965000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8470000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1095000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,603000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-492000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7978000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1039000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6939000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6939000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6939000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,758000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,9.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,766000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.06
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758400000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 16:48:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5329000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,207000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5536000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4465000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1093000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2432000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2033000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,284000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,164000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-120000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1913000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,113000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1800000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1800000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1800000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,758000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.38
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,766000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758400000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.38
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-2.37
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5516000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,207000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5723000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1034000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1034000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4689000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1231000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1119000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2350000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,282000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,135000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2192000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,329000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1863000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1863000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1863000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,757000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.46
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.44
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,757300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.46
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3,2015-07-01,2015-09-30,2016-10-28 16:47:10+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15615000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,511000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3156000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3156000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12970000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3556000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2977000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6533000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6437000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,811000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,439000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-372000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6065000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,926000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,757000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,757300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.37
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20789000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,668000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21457000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4339000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17118000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5011000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4211000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9222000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7896000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1072000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,527000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-545000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7351000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,918000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,757000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.48
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,764000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.38
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,757300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.48
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.54
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5225000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,145000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5370000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1089000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1089000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4281000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1241000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,964000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2205000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2076000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,198000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1997000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,344000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1653000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1653000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1653000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.18
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.18
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2,2015-04-01,2015-06-30,2016-07-29 16:47:26+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10099000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,304000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10403000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2122000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2122000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8281000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2325000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1858000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4183000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4098000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,304000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-225000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3873000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,597000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3276000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.31
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.26
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.31
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.58
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20121000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,644000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20765000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4373000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4373000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16392000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5259000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4110000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9369000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7023000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,532000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-527000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6496000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,682000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,768000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.55
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,758300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4874000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,159000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5033000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1033000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1033000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4000000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1084000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1978000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2022000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,252000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,106000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-146000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1876000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,253000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1623000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1623000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1623000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.11
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 16:49:29+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19845000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,730000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20575000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4365000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4365000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16210000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5197000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4164000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9361000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6849000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1064000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,472000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-592000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,549000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5708000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5708000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5708000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,761000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.51
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.51
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.18
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22991000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22991000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18829000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5195000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3840000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9035000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9794000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1260000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,629000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-631000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9163000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1441000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7722000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7722000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7722000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,748000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,10.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.24
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,748300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,FY,2016-01-01,2016-12-31,2019-02-13 17:20:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-797000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5965000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4898000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1335000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1078000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2413000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2485000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,328000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2283000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,348000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,748000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,748300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5516000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,295000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5811000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1027000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1027000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4784000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1267000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,990000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2527000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,325000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-109000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2418000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,401000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.68
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3,2016-07-01,2016-09-30,2017-10-25 20:00:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16229000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,797000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17026000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3095000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3095000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13931000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3860000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2762000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6622000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7309000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,932000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,503000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-429000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6880000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1093000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5787000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5787000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5787000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,7.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,7.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,7.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21558000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1004000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4166000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4166000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18396000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3855000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9054000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9342000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,667000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-549000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8793000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1206000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.01
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5474000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,214000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5688000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1050000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1050000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4638000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1358000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,900000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2258000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2380000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,313000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,137000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-176000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2204000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,334000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1870000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1870000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1870000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.49
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,756000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.47
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.49
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2,2016-04-01,2016-06-30,2017-07-26 16:37:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10713000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,502000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11215000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2593000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1772000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4365000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4782000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,287000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-320000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4462000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,692000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3770000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.01
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,756000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.97
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.01
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21558000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,916000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22474000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4173000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4173000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18301000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5163000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3984000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9147000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9154000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1173000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,586000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-587000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8567000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1134000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7433000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,756000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,751000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.42
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5239000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,288000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5527000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1018000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1018000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4509000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1235000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,872000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2402000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,294000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2258000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,358000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1900000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1900000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1900000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1,2016-01-01,2016-03-31,2017-04-26 20:16:03+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21309000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,847000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22156000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5046000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4048000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9094000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8850000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1137000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,647000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-490000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8360000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1144000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.54
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,754000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.54
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.21
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22849000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22849000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4069000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4069000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18780000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5245000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8807000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9973000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1304000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-376000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9597000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1979000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1979000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1979000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,731000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,735000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.69
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,730300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.71
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,FY,2017-01-01,2017-12-31,2020-02-12 17:15:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5802000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4743000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1455000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1043000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2498000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2245000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,332000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,301000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-31000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2214000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6478000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4264000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4264000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4264000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,731000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-5.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,735000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-5.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,730300000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-5.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5773000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5773000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,990000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,990000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4783000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1467000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,877000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2344000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2439000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,325000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,267000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2381000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,360000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2021000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,728000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.78
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,733000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.76
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,727000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.78
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3,2017-07-01,2017-09-30,2018-10-30 18:53:11+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16782000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17047000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3010000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3010000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14037000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3790000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2519000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6309000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7728000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,972000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,627000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-345000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7383000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1140000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6243000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6243000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6243000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,728000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,8.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,733000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.46
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,727000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.52
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23544000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-532000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23012000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4077000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4077000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18935000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5125000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3597000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8722000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10213000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1300000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-547000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9666000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1488000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8178000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8178000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8178000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,728000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,733000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,11.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,727000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.6
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5810000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5810000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1024000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1024000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4786000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1215000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,873000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2088000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2698000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,321000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-156000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2542000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,391000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,734000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.93
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,738000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.91
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,734100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.93
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 18:58:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11274000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2020000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2020000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9254000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2323000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1642000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3965000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5289000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,647000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,360000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-287000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5002000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,780000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4222000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4222000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4222000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,734000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.74
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,738000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,734100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.74
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.3
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23287000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-237000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23050000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4114000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4114000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18936000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4925000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3710000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8635000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10301000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1300000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,702000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-598000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9703000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8174000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,734000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,11.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,738000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.97
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,734100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,11.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5464000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,996000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,996000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4468000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1108000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,769000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1877000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2591000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,326000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,195000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-131000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2460000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,389000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2071000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,741000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.81
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1,2017-01-01,2017-03-31,2018-04-24 19:28:44+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22951000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-23000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4140000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4140000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18788000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5068000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8805000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9983000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1292000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9365000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1472000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7893000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7893000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7893000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,741000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.53
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.61
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.3
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23747000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4101000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4101000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19646000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5646000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9383000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10263000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1392000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-718000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9545000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8394000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8394000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8394000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,661000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,665000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.62
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,660900000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.7
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,FY,2018-01-01,2018-12-31,2020-02-12 17:15:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,5.41
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6230000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6230000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1096000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1096000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5134000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1570000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1182000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2752000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2382000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,352000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,155000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-197000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2185000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1928000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,661000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,665000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.03
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,660900000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5904000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5904000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1037000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1037000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4867000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1618000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,926000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2544000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2323000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,355000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-229000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2094000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,235000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1859000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1859000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1859000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,649000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.86
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,645500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3,2018-07-01,2018-09-30,2019-10-29 19:31:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17517000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17517000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3005000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3005000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14512000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4076000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2555000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6631000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7881000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1040000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,519000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-521000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7360000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,894000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6466000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6466000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6466000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,9.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,649000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,9.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,645500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.65
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.64
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23584000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23319000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4064000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4064000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19255000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5531000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3598000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9129000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10126000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1372000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,820000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-552000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9574000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7372000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,649000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.82
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,645500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.84
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.96
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6059000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1024000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1024000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5035000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1334000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,869000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2203000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2832000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,347000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,162000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-185000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2647000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,351000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,660000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.48
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2,2018-04-01,2018-06-30,2019-07-30 19:13:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.5
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11613000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11613000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1968000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1968000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9645000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2458000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1629000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4087000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5558000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,685000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,393000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-292000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5266000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,659000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,660000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.73
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23453000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23188000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5380000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3549000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8929000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10242000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1342000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,961000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-381000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9861000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7497000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2364000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2364000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2364000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.74
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,660000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,656000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.74
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5554000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5554000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4610000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1124000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,760000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1884000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2726000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,338000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,231000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2619000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,308000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2311000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2311000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2311000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,707000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.27
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,711000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.25
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,706700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.27
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1,2018-01-01,2018-03-31,2019-04-30 18:37:54+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23204000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-265000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22939000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4017000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18922000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5261000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3553000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10108000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1316000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,964000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-352000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9756000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7537000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2219000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2219000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2219000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,707000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.17
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,711000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.15
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,706700000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.17
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,4.94
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6197000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6197000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1253000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1253000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4944000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1584000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1312000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2896000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2048000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,301000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,236000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-65000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1983000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,280000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1703000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1703000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1703000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,609000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.86
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,605100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,3.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23362000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23362000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4356000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4356000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19006000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5216000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4116000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9332000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9674000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1289000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,753000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-536000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9138000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1296000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7842000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7842000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7842000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,605000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.96
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,609000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.88
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,605100000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.96
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,FY,2019-01-01,2019-12-31,2020-02-12 17:15:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,5.95
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3103000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3103000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14062000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3632000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2804000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6436000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7626000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,988000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,517000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-471000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7155000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1016000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6139000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,599000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,10.08
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,10.02
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,598200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,10.08
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,2.9
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23395000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23395000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19196000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5202000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3986000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9188000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10008000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1340000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,672000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-668000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9340000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1273000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,599000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,13.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,13.05
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,598200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,13.13
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,5.67
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5737000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1036000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1036000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4701000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1224000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1001000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2225000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2476000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,313000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,114000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2277000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,309000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1968000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1968000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1968000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,599000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.29
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,602000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.27
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,598200000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.29
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q3,2019-07-01,2019-09-30,2019-10-29 19:31:34+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11428000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11428000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2067000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9361000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2408000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1803000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4211000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5150000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,675000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,403000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-272000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4878000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,707000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4171000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,610000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.75
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.79
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23562000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4200000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4200000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19362000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5596000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3911000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9507000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9855000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1382000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,684000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-698000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9157000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1199000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7958000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,610000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.64
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.72
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,5.54
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5871000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5871000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1012000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1012000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4859000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1257000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,924000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2181000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2678000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,332000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,218000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-114000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2564000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,385000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2179000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2179000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2179000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,610000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.57
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,607000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q2,2019-04-01,2019-06-30,2019-07-30 19:13:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.59
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1055000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1055000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4502000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1151000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,879000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2030000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2472000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,343000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,185000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-158000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2314000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,322000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1992000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1992000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1992000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,622000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.2
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,626000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.18
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,622500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.2
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1,2019-01-01,2019-03-31,2020-04-30 20:48:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.45
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23750000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4212000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19538000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5673000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3856000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9529000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10009000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1397000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,628000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-769000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9240000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1165000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8075000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8075000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8075000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,622000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,626000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.55
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,622500000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.63
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,5.54
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23966000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23966000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4814000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19152000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5406000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4189000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9595000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9557000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1292000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,579000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-713000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8844000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1169000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7675000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7675000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7675000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,590000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,594000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.77
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,590600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.85
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1TTM,2019-04-01,2020-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,6.1
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6161000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6161000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1513000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1513000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4648000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1341000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,952000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2293000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2355000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,346000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-335000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2020000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,195000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1825000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1825000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1825000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,590000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,594000000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.07
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,590600000.0
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.09
Amgen Inc,AMGN,62QBXGPJ34PQ72Z12S66,0000318154,2020.0,Q1,2020-01-01,2020-03-31,2020-04-30 20:48:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.6
